๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Cirrhosis and Chronic Liver Disease

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis NCT05335603n/a1 site๐Ÿ“ Hvidovre University of Copenhagen SASL Swiss Cirrhosis Cohort NCT06092385n/a10 sites๐Ÿ“ Lugano๐Ÿ“ Basel๐Ÿ“ Bern University Hospital, Basel, Switzerland ยท Tests: Data collection 2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices NCT07122622n/a1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG NCT06863012NA1 site๐Ÿ“ Barcelona Fundacio Privada Mon Clinic Barcelona ยท Tests: Endoscopic Ultrasound-Guided Portal Pressure Gradient (EUS-PPG) Measurement, Hepatic Venous Pressure Gradient (HVPG) Meโ€ฆ Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study NCT06948565n/a1 site๐Ÿ“ Besanรงon Centre Hospitalier Universitaire de Besancon ยท Tests: observational study Non-Invasive Model for Fibrosis Regression in HBV Patients NCT06874127n/a1 site๐Ÿ“ Beijing Beijing Friendship Hospital ยท Tests: Nucleos(t)ide Analogs (NA) Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis NCT04588077Phase 41 site๐Ÿ“ Baltimore Mercy Medical Center ยท Tests: Heplisav-B Injectable Product, 2-dose regimen, Heplisav-B Injectable Product, 3-dose regimen hepatomiR cACLD Study NCT06432582n/a1 site๐Ÿ“ Sankt Pรถlten Karl Landsteiner University of Health Sciences ยท Tests: hepatomiR Comparison of Blood Products Required Using Two Different ROTEM Cut-offs Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure (ACLF) Patients With Severe Coagulopathy NCT06831565NA1 site๐Ÿ“ New Delhi Institute of Liver and Biliary Sciences, India ยท Tests: ROTEM Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival NCT06431919NA1 site๐Ÿ“ Chandigarh Post Graduate Institute of Medical Education and Research, โ€ฆ ยท Tests: Simvastatin 20mg, Carvedilol 3.125 mg The Liver Cirrhosis Cognitive Decline Scale (LiCCoS) NCT07418008n/a1 site๐Ÿ“ Ambฤla University of Malaya 3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension NCT05475015n/a1 site๐Ÿ“ Shenyang Shengjing Hospital ยท Tests: 3D-MRE, HVPG Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI NCT05486572NA34 sites๐Ÿ“ Birmingham๐Ÿ“ Tucson๐Ÿ“ Little Rock VA Office of Research and Development ยท Tests: Abbreviated Magnetic Resonance Imaging with serum AFP, Abdominal Ultrasound Screening with serum AFP Assessing Signatures for Fibrosis Detection in Chronic Liver Disease: A Step Beyond Conventional Biomarkers NCT07359742NA1 site๐Ÿ“ Brussels Universitair Ziekenhuis Brussel ยท Tests: Blood draw for biomarkers Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease NCT04578301n/a1 site๐Ÿ“ Bonn University Hospital, Bonn ยท Tests: No Intervention A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device. NCT07347275NA1 site๐Ÿ“ London Yaqrit Ltd ยท Tests: Standard of Care (Investigator Choice), DIALIVE 2.0 liver dialysis Device plus available Standard of Care Copper Supplementation in Cirrhosis NCT07471542NA1 site๐Ÿ“ Seattle University of Washington ยท Tests: Copper Gluconate Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer NCT06658782n/a2 sites๐Ÿ“ Oxford๐Ÿ“ Bournemouth University of Oxford ยท Tests: non contrast enhanced MRI Impact of Liver Transplantation on Sexual Life and Function NCT07268196n/a1 site๐Ÿ“ New Delhi Institute of Liver and Biliary Sciences, India ยท Tests: No Treatment Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis NCT07438288n/a3 sites๐Ÿ“ Singapore๐Ÿ“ Singapore๐Ÿ“ Singapore Singapore General Hospital ยท Tests: Observation Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome NCT06519162n/a1 site๐Ÿ“ Daejeon Chungnam National University Hospital Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai) NCT06767605n/a1 site๐Ÿ“ Barcelona Asociaciรณn Espaรฑola para el Estudio del Hรญgado Whole-life Investigation of Lishui Longevity NCT07592962n/a1 site๐Ÿ“ Lishui The Fifth Affiliated Hospital of Wenzhou Medical Universityโ€ฆ Measuring Patient Reported Needs in Outpatient Liver Disease Management NCT07191886n/a1 site๐Ÿ“ Indianapolis Indiana University Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease NCT02060565n/a1 site๐Ÿ“ Pessac Association HGE CHU Bordeaux Sud LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease NCT05998330NA1 site๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: LiverPAL VACcination of LIver Transplantation Candidates NCT04446832n/a1 site๐Ÿ“ Lyon Hospices Civils de Lyon ยท Tests: Vaccine immunogenicity A Study of SIPLIZUMAB in AILD and LT Patients NCT06455280Phase 11 site๐Ÿ“ New York Elizabeth C. Verna ยท Tests: Siplizumab Correlation Of EUS-SWQ And Liver Fibrosis Pathology In Chronic Liver Disease NCT07588854n/a1 site๐Ÿ“ Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Scโ€ฆ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy